Viewing Study NCT01161368


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-29 @ 8:23 AM
Study NCT ID: NCT01161368
Status: TERMINATED
Last Update Posted: 2015-08-13
First Post: 2010-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients
Sponsor: Central European Cooperative Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module